Categories
Education, Science, Life Sciences
Number of episodes
1
Published on
2024-05-07 20:45:00
Language
English
Listeners can expect to learn about: • The disease burden and underlying pathophysiology of IgA nephropathy, including the role of endothelin and angiotensin in disease progression • The current IgAN treatment landscape • The response to sparsentan, a dual endothelin angiotensin receptor antagonist, in patients with IgA nephropathy in the phase 3 PROTECT trial
| Type | Link |
|---|---|
|
Feed |
|
|
Apple Podcasts |
© 2025 Travere Therapeutics
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.